Journal: The World Journal of Men's Health
Article Title: A Highly Sensitive Methylation Assay for Prostate Cancer Diagnosis
doi: 10.5534/wjmh.240182
Figure Lengend Snippet: A panel of methylation sites for PCa diagnosis. (A) Distribution of DNA methylation abundance at the GSTP1, ADCY4, and HOXA7 sites in plasma free DNA from ACs (n=17) and PCa (n=55). Red areas indicate below the detection limit of the assay and fluorescence intensity is indistinguishable from WT. (B) ROC curve of the 3-gene detection panel. (C) PCa patients and healthy population controls for plasma free DNA methylation variability were determined with a sensitivity of 89% for this method. (D–F) The relationship between methylation patterns and Gleason score (D), PSA level (E), and PI-RADS score (F). PCa: prostate cancer, AC: asymptomatic control, WT: wild type, PSA: prostate-specific antigen, PI-RADS: prostate imaging-reporting and data system. Statistically significant ( * p<0.05, ** p<0.01, *** p<0.001).
Article Snippet: Additionally, the EZ DNA Methylation Bisulfite Conversion Kit was acquired from Zymo Research.
Techniques: Methylation, Biomarker Discovery, DNA Methylation Assay, Clinical Proteomics, Fluorescence, Control, Imaging